应用皮下负压引流器预防下消化道开放手术切口愈合不良回顾性队列研究

目的 探讨应用皮下负压引流器预防下消化道开腹手术切口愈合不良的价值。方法 回顾性分析2018年10月至2020年1月首都医科大学附属北京友谊医院普外科收治的113例下消化道开放手术病人的临床资料。根据腹壁缝合时是否放置皮下引流器,分为皮下引流组（78例）和对照组（35例）。比较两组病人切口愈合情况,分析切口愈合不良与临床特征的关系以及开放手术切口愈合不良的影响因素。结果 113例病人中,切口愈合不良发生率为14.2%（16/113）,其中皮下引流组切口愈合不良发生率为5.1%（4/78）,对照组为34.3%（12/35）,两组差异具有统计学意义（P<0.05）。多因素分析提示,影响切口愈合不良发生的独立危险因素为未放置皮下引流器（OR=14.510,95%CI 3.411~61.735,P=0.001）、糖尿病（OR=7.064,95%CI 1.286~38.789,P=0.024）及吻合口漏/残端漏（OR=15.004,95%CI 1.876~119.996,P=0.011）。结论 下消化道开放手术切口愈合不良发生率较高,应用皮下负压引流器能有效减少其发生,且操作方便、价格低廉。     

Laparoscopic <Emphasis Type="Italic">versus</Emphasis> open splenectomy and devascularization for massive splenomegaly due to portal hypertension

Although the clinical benefit of laparoscopic splenectomy and devascularization (LSD) has been elaborated in many studies, its application in massive splenomegaly remains controversial. We conducted a retrospective research to assess the curative efficacy of LSD for massive splenomegaly due to portal hypertension. Forty-seven patients with massive splenomegaly due to portal hypertension were enrolled in this study, and divided into two groups. Twenty-one patients underwent open splenectomy and devascularization (OSD) from June 2010 to October 2012 (OSD group). From March 2013 to February 2015, LSD was performed on 26 patients (LSD group). Perioperative variables were analyzed. Compared to OSD, LSD was associated with less blood loss (241.9±110.0 mL vs. 319.0±139.5 mL, P<0.05), more rapid resumption of oral diet (2.46±0.95 days vs. 3.76±1.09 days, P<0.05), and shorter postoperative hospital stay (5.35±1.65 days vs. 7.24±1.55 days, P<0.05). It was concluded that for patients with massive splenomegaly due to portal hypertension, LSD is feasible and as safe as OSD.